SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1752Yes, interesting. Regarding: <<In their gene expression business, Incyte CYBERKEN-4/29/2001
1751Interesting post from MF thread; companysleuth.comsmh-4/29/2001
1750<Of course, Whitfield, who is refreshingly direct, says that this vision willsmh-4/26/2001
1749Encouraging that they have done a little more thinking, but where did they get tnigel bates-4/26/2001
1748Motley Fool belatedly works out that INCY might have a more attractive business RCMac-4/26/2001
1747INCY beats the estimates on the loss side: biz.yahoo.com Wednesday April 25, 4Glenn Petersen-4/25/2001
1746Revenues keep growing at least: biz.yahoo.com DAKLLCF-4/25/2001
1745<i>In 1992, he co-founded a company called Genome Systems, which Incyte acnigel bates-4/23/2001
1744DNA DEPOT Warehouse in St. Louis ships gene fragments to thousands of scientistsmh-4/22/2001
1743Merck Licenses Enabling Microarray Manufacturing and Gene Expression Technology nigel bates-4/11/2001
1742Venter, Haseltine, Ellison: Celebrities, stars, wealth, glamour, self-promotion.Doc Bones-4/10/2001
1741Biotech CEO says map missed much of genome By Raja Mishra, Globe Staff, 4/9/20Mark Bong-4/10/2001
1740PALO ALTO, Calif., and TOKYO, April 9 /PRNewswire/ -- Incyte Genomics, Inc. (Nasnigel bates-4/9/2001
1739Yes. Looks like one more poorly-researched and hurried piece of journalism. The CYBERKEN-4/9/2001
1738Interesting that INCY is not even on BW's bioinformatics radar screen. Messim1-4/9/2001
1737Incyte Upgraded to "Strong Buy" by Lehman this morning! eom.Mike K-4/2/2001
1736Thanks. There were a few interesting references I didn't know about. What iTorben Noerup Nielsen-3/25/2001
1735TNN, You are not alone. Message 15560170smh-3/25/2001
1734What they are doing is *hard* even from a simple CS point of view. You'd norTorben Noerup Nielsen-3/25/2001
1733Perhaps, then, describing what Incyte is doing as simply "annotating" CYBERKEN-3/25/2001
1732upside.com ... Information overload Culling useful information from the hugesmh-3/25/2001
1731Affymetrix settles with OGT - Message 15557843nigel bates-3/24/2001
1730TA is not my bag and I would just be guessing if I gave a reply. The following Lighthouse-3/22/2001
1729That would seem to present INCY as a nearly fail safe value prospect if you are Raymond Clutts-3/22/2001
1728The following is pure conjecture and subject to the delusions of the author. PleLighthouse-3/22/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News